United States· US:0527-6584_28336547-2194-432f-8dbd-f81b2cc4ef2d
METADATE CD
A methylphenidate product containing methylphenidate hydrochloride, registered in United States by Lannett Company, LLC. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Methylphenidate is registered in 18 of 19 countries.
Countries holding a registration under ATC N06BA04 (methylphenidate), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Methylphenidate · ATC N06BA04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of methylphenidate costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.56 in France to $1.87 in Switzerland — a ×3.4 gap.
- United States: $0.56 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Methylphenidate · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.87
- IT Italy$0.68
- US United States$0.56 (acquisition cost)
- FR France$0.56
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- METHYLPHENIDATE HYDROCHLORIDE
- Manufacturer
- Lannett Company, LLC
- Country
- United States (US)
- ATC code
- N06BA04
- ATC class
- Methylphenidate
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc110527-6584-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
196 interactions on record for methylphenidate.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methylphenidate · interactions on record
196 records
- 12 severe
- 45 moderate
- 3 minor
- 128 info
Most severe, free to view
- ProcarbazineL01XB01severe
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- CocaineN01BC01severe
8 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methylphenidate in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenAffenid 60 mg Kapsel med modifierad frisättning, hårdZentiva k.s.
- NetherlandsEquasym XL 60 mg, capsule met gereguleerde afgifte, hardTakeda Pharmaceuticals International AG Ireland Branch
- United KingdomMedikinet XL 60mg capsulesMedice UK Ltd
- IcelandMedikinet CRMedice Arzneimittel Pütter GmbH & Co. KG*
- SpainLUMENTA 60 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFGLaboratorio Stada S.L.
- NorwayMedikinetMedice Arzneimittel Pütter GmbH & Co KG
- BelgiumEquasym XR 60 mgTakeda Pharmaceuticals International Ireland Branch
- PolandAdehaderHumantis GmbH
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Concerta, Conmethyl
- Belgium · Atexam 18 Mg, Atexam 27 Mg
- Bulgaria · Концерта
- Cyprus · Concerta
- Czechia · Balipre, Concerta
- Germany · 5 Mg, Medikinet, 50 Mg, Medikinet Adult
- Denmark · Concerta, Equasym Depot
- Estonia · Affenid, Concerta
- Spain · Atenza, Concerta
- Finland · Atexam, Concerta
- France · Concerta Lp, Lp
- United Kingdom (Northern Ireland) · Addepta Xl, Affenid Xl
- Greece · Concerta
- Croatia · Concerta, Mefeda
- Hungary · Ritalin, Ritalin La
- Ireland · Concerta Xl, Equasym Xl
- Iceland · Concerta, Equasym Depot
- Italy · Equasym, Medikinet
- Liechtenstein · Concerta, Tuzulby
- Lithuania · Concerta, Medikinet
- Luxembourg · Concerta, Equasym Xr
- Latvia · Medikinet, Medikinet Xl
- Malta · Concerta, Concerta Xl
- Netherlands · Concerta, Equasym Xl
- Norway · Concerta, Delmosart
- Poland · Adehader, Atenza
- Portugal · Atexam, Concerta
- Romania · Clorhidrat De Metilfenidat G.L. Pharma, Concerta
- Sweden · Affenid, Concerta
- Slovenia · Concerta
- Slovakia · Balipre, Concerta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/15fb32c9-0a67-42c9-a589-591dbd7b0729 GET /v1/drugs/15fb32c9-0a67-42c9-a589-591dbd7b0729?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "60",
"substance": "METHYLPHENIDATE HYDROCHLORIDE",
"productndc": "0527-6584",
"dosage_form": "CAPSULE, EXTENDED RELEASE",
"dea_schedule": "CII",
"strength_unit": "mg/1",
"application_number": "NDA021259",
"marketing_category": "NDA"
}See everything about methylphenidate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.